Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

Knowledge

  1. Home>
  2. News>
  3. Knowledge>
  4. Page 8

Understanding India’s Drug Price Control: NPPA, NLEM and Generic Medicine Pricing

  • Post published:August 15, 2026
  • Post category:Knowledge

If you've ever wondered why a generic medicine costs ₹20 in one pharmacy and ₹80 in another—or why the government can (or cannot) cap what pharma companies charge—you're looking at…

Continue Reading Understanding India’s Drug Price Control: NPPA, NLEM and Generic Medicine Pricing

Importing Indian Generic Medicines: A 2026 Customs & Documentation Guide

  • Post published:August 10, 2026
  • Post category:Knowledge

Buying Indian generic medicines across borders is one of the smartest ways to cut long-term healthcare costs, but the process is only smooth when you understand the customs, documentation and…

Continue Reading Importing Indian Generic Medicines: A 2026 Customs & Documentation Guide

Understanding Biosimilars in India: CDSCO Approval & Buyer’s Guide 2026

  • Post published:August 8, 2026
  • Post category:Knowledge

India is known as the "Pharmacy of the World" for its low-cost generic medicines, but a quieter revolution is underway in a different category: biosimilars. These are near-copies of complex…

Continue Reading Understanding Biosimilars in India: CDSCO Approval & Buyer’s Guide 2026

Understanding Generic Semaglutide: A 2026 Buyer’s Guide to Indian GLP-1 Options

  • Post published:August 6, 2026
  • Post category:Knowledge

Semaglutide — the active ingredient in Novo Nordisk’s Ozempic (for type 2 diabetes) and Wegovy (for weight management) — has become one of the most in-demand medicines in the world.…

Continue Reading Understanding Generic Semaglutide: A 2026 Buyer’s Guide to Indian GLP-1 Options
  • Go to the previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 69
  • Go to the next page

Recent Posts

  • How India Trains Drug Inspectors: WHO Fellowship & GMP Checks
    November 17, 2026/
    0 Comments
  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • How India Trains Drug Inspectors: WHO Fellowship & GMP Checks
  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve